# Traws Pharma, Inc.: filings

TRAW · Nasdaq · CIK 1130598 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/traw.md) · [Financials](/companies/traw/financials.md) · [Filings](/companies/traw/filings.md) · [Insiders](/companies/traw/insiders.md)

## Reports and events: 342 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 323, 8-K 224, 3 41, 10-Q 40, CORRESP 29, DEFA14A 23, 424B5 21, UPLOAD 20, DEF 14A 19, SC 13G 18, SC 13G/A 17, EFFECT 16, S-1/A 15, 10-K 13, 424B3 13, SCHEDULE 13G/A 13, S-8 11, PRE 14A 10, S-3 9, SCHEDULE 13G 9, D 8, SC 13D/A 8, 10-K/A 7, 424B4 6, ARS 6, S-1 6, 3/A 5, SC 13D 5, 144 3, 8-K/A 3, D/A 3, FWP 3, S-3/A 3, 4/A 2, 8-A12B 2, CERTNAS 2, CT ORDER 2, POS AM 2, SCHEDULE 13D/A 2, SEC STAFF LETTER 2, 25-NSE 1, 424B2 1, DRS 1, NT 10-K 1, NT 10-Q 1, PRER14A 1, S-1MEF 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 17:18 ET | [8-K](/filings/0001104659-26-118519.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-26-118519 |
| 2026-10-20 | 16:05 ET | [DEF 14A](/filings/0001104659-26-117406.md) | Proxy statement, period 2026-12-03 | 0001104659-26-117406 |
| 2026-08-14 | 16:35 ET | [10-Q](/filings/0001104659-26-097261.md) | Quarterly report, period 2026-06-30 | 0001104659-26-097261 |
| 2026-08-14 | 16:30 ET | [8-K](/filings/0001104659-26-097226.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-097226 |
| 2026-07-31 | 16:15 ET | [8-K](/filings/0001104659-26-089220.md) | 3.01 Delisting notice | 0001104659-26-089220 |
| 2026-07-10 | 16:02 ET | [8-K](/filings/0001104659-26-082649.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-082649 |
| 2026-07-09 | 16:01 ET | [8-K](/filings/0001104659-26-082250.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-082250 |
| 2026-06-22 | 07:00 ET | [8-K](/filings/0001104659-26-076058.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-076058 |
| 2026-06-12 | 17:25 ET | [8-K](/filings/0001104659-26-073593.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-073593 |
| 2026-05-29 | 09:00 ET | [DEF 14A](/filings/0001104659-26-067945.md) | Proxy statement, period 2026-07-08 | 0001104659-26-067945 |
| 2026-05-27 | 08:50 ET | [8-K](/filings/0001104659-26-066623.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-066623 |
| 2026-05-26 | 17:09 ET | [8-K](/filings/0001104659-26-066345.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-066345 |
| 2026-05-15 | 07:10 ET | [10-Q](/filings/0001104659-26-061779.md) | Quarterly report, period 2026-03-31 | 0001104659-26-061779 |
| 2026-05-15 | 07:05 ET | [8-K](/filings/0001104659-26-061771.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-061771 |
| 2026-05-05 | 18:55 ET | [SCHEDULE 13D/A](/filings/0000947871-26-000492.md) | Ownership report, active investor, amended | 0000947871-26-000492 |
| 2026-04-30 | 16:35 ET | [10-K/A](/filings/0001104659-26-053041.md) | Annual report, amended, period 2025-12-31 | 0001104659-26-053041 |
| 2026-04-15 | 16:47 ET | [10-K](/filings/0001104659-26-043832.md) | Annual report, period 2025-12-31 | 0001104659-26-043832 |
| 2026-04-15 | 16:02 ET | [8-K](/filings/0001104659-26-043781.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-043781 |
| 2026-04-15 | 08:00 ET | [8-K](/filings/0001104659-26-043497.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-043497 |
| 2026-02-19 | 08:42 ET | [8-K](/filings/0001104659-26-017298.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-017298 |
| 2026-01-26 | 08:30 ET | [8-K](/filings/0001104659-26-006460.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-006460 |
| 2026-01-13 | 07:00 ET | [8-K](/filings/0001104659-26-003071.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-003071 |
| 2025-12-17 | 06:00 ET | [8-K](/filings/0001104659-25-121749.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-121749 |
| 2025-12-16 | 17:00 ET | [8-K](/filings/0001104659-25-121635.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-121635 |
| 2025-11-28 | 16:30 ET | [8-K](/filings/0001104659-25-116962.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-116962 |
| 2025-11-13 | 07:30 ET | [10-Q](/filings/0001104659-25-110845.md) | Quarterly report, period 2025-09-30 | 0001104659-25-110845 |
| 2025-11-13 | 07:01 ET | [8-K](/filings/0001104659-25-110829.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-110829 |
| 2025-10-17 | 17:03 ET | [8-K](/filings/0001104659-25-100455.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-100455 |
| 2025-10-14 | 07:00 ET | [8-K](/filings/0001104659-25-098994.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-098994 |
| 2025-10-08 | 16:16 ET | [DEF 14A](/filings/0001104659-25-097926.md) | Proxy statement, period 2025-11-21 | 0001104659-25-097926 |
| 2025-10-06 | 07:00 ET | [8-K](/filings/0001104659-25-096920.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-096920 |
| 2025-09-12 | 16:33 ET | [8-K](/filings/0001104659-25-089564.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001104659-25-089564 |
| 2025-08-18 | 07:01 ET | [8-K](/filings/0001104659-25-079454.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-079454 |
| 2025-08-14 | 07:01 ET | [8-K](/filings/0001104659-25-078060.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-078060 |
| 2025-08-14 | 07:00 ET | [10-Q](/filings/0001558370-25-011469.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011469 |
| 2025-07-03 | 17:08 ET | [8-K](/filings/0001104659-25-065842.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-065842 |
| 2025-06-30 | 06:31 ET | [8-K](/filings/0001104659-25-063793.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-063793 |
| 2025-06-03 | 07:01 ET | [8-K](/filings/0001104659-25-055709.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-055709 |
| 2025-05-27 | 08:01 ET | [8-K](/filings/0001104659-25-052729.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-052729 |
| 2025-05-19 | 08:00 ET | [8-K](/filings/0001104659-25-050242.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-050242 |
| 2025-05-15 | 16:01 ET | [10-Q](/filings/0001558370-25-007872.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007872 |
| 2025-05-15 | 07:00 ET | [8-K](/filings/0001104659-25-048915.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-048915 |
| 2025-04-30 | 16:31 ET | [10-K/A](/filings/0001558370-25-006013.md) | Annual report, amended, period 2024-12-31 | 0001558370-25-006013 |
| 2025-04-18 | 16:45 ET | [8-K](/filings/0001104659-25-036366.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-036366 |
| 2025-04-07 | 17:03 ET | [8-K](/filings/0001104659-25-032684.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-032684 |
| 2025-03-31 | 16:35 ET | [10-K](/filings/0001558370-25-004165.md) | Annual report, period 2024-12-31 | 0001558370-25-004165 |
| 2025-03-31 | 09:21 ET | [8-K](/filings/0001104659-25-029687.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-029687 |
| 2025-03-28 | 16:30 ET | [8-K](/filings/0001104659-25-029405.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-029405 |
| 2025-03-25 | 07:30 ET | [8-K](/filings/0001104659-25-027545.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-027545 |
| 2025-03-24 | 07:00 ET | [8-K](/filings/0001104659-25-026854.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-026854 |

Page 1 of 7. [Older](/companies/traw/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:48 ET. No prices; not investment advice.